FAM
ABBV icon

Flaharty Asset Management’s AbbVie ABBV Stock Holding History

Flaharty Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-54
Closed -$11.3K – 131
2025
Q1 		$11.3K Buy
+54
New +$10.5K ﹤0.01% 315
2024
Q4 		– Sell
-54
Closed -$10.7K – 129
2024
Q3 		$10.7K Buy
+54
New +$10.1K ﹤0.01% 312
2023
Q4 		– Sell
-142
Closed -$21.2K – 118
2023
Q3 		$21.2K Buy
+142
New +$20.8K ﹤0.01% 260

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Flaharty Asset Management's ABBV Position: Q2 2025 in Review

Flaharty Asset Management sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 54 shares — an estimated $11.3K sold.

Flaharty Asset Management first reported a position in ABBV in Q3 2023 and held it in 3 quarters. The position peaked at $21.2K in Q3 2023. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Flaharty Asset Management reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Flaharty Asset Management sold 54 AbbVie shares in Q2 2025, an estimated $11.3K.
  • Flaharty Asset Management first reported a position in AbbVie in Q3 2023 and held it in 3 quarters.
  • Flaharty Asset Management's AbbVie position peaked at $21.2K in Q3 2023.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Flaharty Asset Management's 13F filing for Q2 2025, filed 8 Aug 2025.